ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating
Announcement as on 11 September 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "Glenmark Expands Global Respiratory Innovation Footprint with RYALTRIS® Launch in Brazil ".
Announcement as on 11 September 2026

Glenmark Pharmaceuticals Ltd soars 1.8%, rises for third straight session
Glenmark Pharmaceuticals Ltd is quoting at Rs 2443.1, up 1.8% on the day as on 12:49 IST on the NSE. The stock is up 26.13% in last one year as compared to a 0.91% fall in NIFTY and a 22.33% fall in the Nifty Pharma index.
Announcement as on 26 August 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL), 5,000 mg/50 mL (100 mg/mL) Single-D
Announcement as on 21 August 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray".
Announcement as on 20 August 2026

Announcements by Glenmark Pharmaceuticals Limited first page | Next page | Prev page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2272.3
  • 12Day Average: 2324.98
  • 20Day Average: 2367.53
  • 50Day Average: 2362.43
  • 100Day Average: 2293.87
  • 150Day Average: 2274.14
  • 200Day Average: 2209.78

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2317.79, 2351.04, -16.09
Indicator MACD is in negative zone

Indicator ADX (14)

40.6, 10.61, 25.11
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
12 Mon Oct 2026 2283.00 2252.00 to 2293.90 -0.44% 0.87 times
09 Fri Oct 2026 2293.00 2203.00 to 2293.00 4.6% 0.52 times
08 Thu Oct 2026 2192.20 2181.20 to 2284.00 -3.95% 1.02 times
07 Wed Oct 2026 2282.30 2274.40 to 2326.80 -1.24% 0.63 times
06 Tue Oct 2026 2311.00 2277.30 to 2320.00 0.7% 0.62 times
05 Mon Oct 2026 2295.00 2273.50 to 2340.50 -1.54% 0.61 times
01 Thu Oct 2026 2331.00 2279.30 to 2360.00 -0.16% 1.22 times
30 Wed Sep 2026 2334.70 2334.70 to 2410.00 -4.37% 1.58 times
29 Tue Sep 2026 2441.50 2292.00 to 2441.50 4.98% 1.6 times
28 Mon Sep 2026 2325.70 2307.30 to 2392.50 -2.28% 1.23 times
25 Fri Sep 2026 2380.00 2365.70 to 2435.20 -2.07% 0.98 times
24 Thu Sep 2026 2430.40 2422.00 to 2470.00 -1.8% 0.57 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top